Knowledge of human papillomavirus and self-sampling, including vaccination practices among female students in Free State, South Africa
- PMID: 40848138
- DOI: 10.1007/s10552-025-02049-5
Knowledge of human papillomavirus and self-sampling, including vaccination practices among female students in Free State, South Africa
Abstract
Background and aim: Human papillomavirus (HPV)-related cancers, especially cervical cancer, remain highly prevalent in low- and middle-income countries, despite the availability of preventive measures such as vaccination and self-sampling screening, due to limited HPV awareness. The study aimed to assess the knowledge of HPV, HPV vaccination practices, and HPV self-sampling awareness and perceptions among female students at the University of the Free State in Bloemfontein, South Africa.
Methods: Data were collected from female university students through a self-administered questionnaire distributed via the secure web-based platform Research Electronic Data Capture (REDCap). HPV infection and vaccination knowledge were measured using a self-administered questionnaire. Knowledge was assessed by assigning one (1) point for each correct answer, while incorrect or "don't know" responses received a score of zero (0). A knowledge score above 75% was categorized as "good knowledge." The data were analyzed using SAS version 9.4.
Results: The study included 381 participants with a median age (interquartile range, IQR) of 23.0 (20-26) years. The findings showed that while 40.9% of participants had good knowledge of HPV infection, only 9.7% demonstrated good knowledge of HPV vaccination, and 13.3% had good overall knowledge. Only 13.4% of participants reported having received the HPV vaccine, while 19.1% expressed unwillingness to receive the vaccine. Barriers to vaccine uptake included lack of information about the HPV vaccine (46.0%) and safety concerns (46.0%). The majority (78.2%) were unaware of HPV self-sampling. Having heard about HPV self-sampling was predictive for HPV knowledge (OR: 2.684, 95% CI: 1.389-5.188, p = 0.003).
Conclusion: These findings suggest that while some participants are informed about HPV infection, the majority are not well-informed about HPV vaccination and are unaware of HPV self-sampling. Additionally, barriers to HPV vaccination persist. Targeted educational interventions are needed to address awareness and knowledge gaps and vaccine hesitancy. These interventions could significantly improve HPV and cervical cancer prevention outcomes.
Keywords: Human papillomavirus; Knowledge; Public health; Self-sampling; Vaccination.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethics approval and consent to participate: Ethics approval was obtained from the University of the Free State Health Sciences Research Ethics Committee (UFS HSREC) (HSD2023/2368/2702). Institutional gatekeepers also granted permission to conduct the research. Consent to participate: Participation was voluntary, and implicit consent was inferred upon survey completion. Consent for publication: Not Applicable.
Similar articles
-
Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD013430. doi: 10.1002/14651858.CD013430.pub2. Cochrane Database Syst Rev. 2025. PMID: 40232221 Free PMC article.
-
Face-to-face interventions for informing or educating parents about early childhood vaccination.Cochrane Database Syst Rev. 2018 May 8;5(5):CD010038. doi: 10.1002/14651858.CD010038.pub3. Cochrane Database Syst Rev. 2018. PMID: 29736980 Free PMC article.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Drivers of human papillomavirus vaccine uptake in migrant populations and interventions to improve coverage: a systematic review and meta-analysis.Lancet Public Health. 2025 Aug;10(8):e693-e711. doi: 10.1016/S2468-2667(25)00148-3. Lancet Public Health. 2025. PMID: 40738554
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
References
-
- Bi H, Zhang D, Xiao B (2023) Association between human papillomavirus infection and common sexually transmitted infections, and the clinical significance of different Mycoplasma subtypes. Front Cell Infect Microbiol 13:1145215. https://doi.org/10.3389/fcimb.2023.1145215 - DOI - PubMed - PMC
-
- Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in South Africa (2023). Summary Report. https://hpvcentre.net/statistics/reports/XWX.pdf . 10 Mar 2023 (Accessed 12 Jan 2025)
-
- Milano G, Guarducci G, Nante N, Montomoli E, Manini I (2023) Human papillomavirus epidemiology and prevention: is there still a gender gap? Vaccines 11(6):1060. https://doi.org/10.3390/vaccines11061060 - DOI - PubMed - PMC
-
- Ondondo RO, Bukusi EA, Kiptoo M, Mpoke S (2020) Cellular immune responses against natural human papillomavirus infections among men in Kisumu, Kenya. Clin Immunol 212:108211. https://doi.org/10.1016/j.clim.2019.05.001 - DOI - PubMed
-
- Shanmugasundaram S, You J (2017) Targeting persistent human papillomavirus infection. Viruses 9(8):229. https://doi.org/10.3390/v9080229 - DOI - PubMed - PMC
LinkOut - more resources
Full Text Sources